Positive results from the DISCOVER trial will support a filing to expand Descovy's use into PrEP, an indication that has been lucrative for Truvada.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2025,